Melanoma March is around the corner
2 February 2015
Our fourth annual Melanoma March is fast approaching and with 23 marches happening all over Australia; it is almost time to march for a cure and help us raise over $1 million for vital melanoma research.
Thanks to everyone who has already registered to march in 2015 and has been fundraising to help us reach our goal. Imagine what $1 million could do for melanoma research.
Melanoma March will officially launch with its first marches happening on the 22nd February and continue throughout the month of March with people getting involved all around the country. If you register before the 20th February, you will go into a draw to win a $500 fuel voucher.
You can also help raise money by buying a raffle ticket for only $10 for your chance to win a Toyota Yaris.
Sunday, 22 February 2015 - Melbourne
Sunday, 22 February 2015 -Wollongong
Saturday, 28 February 2015 - Bribie Island
Sunday, 8 March 2015 - Bunbury
Sunday, 15 March 2015 - Canberra
Saturday, 21 March 2015 -Gosford
Saturday, 21 March 2015 - Taree
Sunday, 22 March 2015 - Adelaide
Sunday, 22 March 2015 - Bathurst
Sunday, 22 March 2015 - Bonny Hills
Sunday, 22 March 2015 - Brisbane
Sunday, 22 March 2015 - Cairns
Sunday, 22 March 2015 - Coolangatta
Sunday, 22 March 2015 - Darwin
Sunday, 22 March 2015 - Perth
Sunday, 22 March 2015 - Manly
Sunday, 22 March 2015 - Rockingham
Sunday, 22 March 2015 - Townsville
Sunday, 22 March 2015 - Wagga Wagga
Sunday, 22 March 2015 - Perth
Sunday, 29 March 2015 - Busselton
Sunday, 29 March 2015 - Karratha
Sunday, 29 March 2015 - Picton
Research projects led by MIA have been awarded almost $6 million in the latest NHMRC funding round which will enable vital progression of research into melanoma prevention and treatment.
The last decade has seen a surge in therapeutic options for advanced melanoma patients, thanks to research. However, not every patient responds to treatment and researchers are taking on the challenge to find out why.
Our first Global Melanoma Research Report shares selected research from around the world and here at MIA that is making a difference to the lives of melanoma patients now and in the future.
After 18 years as Director of the Sydney Melanoma Unit and then Executive Director of Melanoma Institute Australia, Professor John Thompson AO will step down from the position at the end of 2016.
Australian melanoma clinical practice guidelines have been published on a wiki platform for the first time as researchers try to keep up to date with emerging evidence.
Carole Renouf, CEO of Melanoma Institute Australia is asking young Australians who have been affected by melanoma to share their experiences with her.
Melanoma Institute Australia CEO Carole Renouf wants to make sure Aussies remember to take care of our skin as the festive season draws closer and we spend more time in the sun.
Can an individual’s risk factors for melanoma be used to tailor skin self-examinations and surveillance programs?
Prof Georgina Long has been appointed President-Elect Society for Melanoma Research (SMR).
The Australasian Melanoma Conference is bringing together some of the world's leading researchers and clinicians.
Best practice guidelines for melanoma care have gone digital with the first-ever online guidelines developed to adapt to the rapid change in clinical management.
Congratulations are in order for two of our talented researchers.
Professor Richard Scolyer will be sharing his expertise on melanoma pathology at the upcoming Australasian Melanoma Conference. Here he discusses what he'll be presenting on.
Researchers at MIA have established a High Risk Clinic to monitor people at very high risk of developing melanoma.
A generous donation has enabled a medical oncologist from Portugal to learn from the best in the world at MIA.
MIA is hosting a conference to bring together greats minds in melanoma research that will make a difference to the lives of melanoma patients
Meet Michelle, our Translational Research Officer whose role is to connect the clinics to the lab by ensuring patient blood and tissue samples are documented and carefully stored in our BioSpecimen Bank.
Dr James Wilmott says his Wildfire Award will help expand research into treatment options for people with mucosal melanoma, a rare but deadly form of skin cancer.
Following the recent hype around immunotherapies in cancer, CEO Carole Renouf shares the greatest story never told… resistance… and what MIA is doing to address it.
A/Prof Wargo discusses the research she will be presenting as a keynote speaker at the upcoming Australasian Melanoma Conference.